Month: March 2020

NOACs differ with regard to bleeding risk

Non-vitamin K antagonist Oral Anticoagulants (NOACs) have become the mainstay therapy for stroke prophylaxis in atrial fibrillation. Although shown equally or more safe and effective than warfarin, there is limited knowledge of the comparative effectiveness and safety of the NOACs…. Read More ›